| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$343 |
Colossus PFS Unlocks World-Class Project Economics
|
9 Jul 2025 9:31AM |
$0.515 |
$2.650 |
risen by
414.56%
|
|
VMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Colossus Project PFS demonstrates world-class project economics with high margins and low operating costs.
- The project targets high-grade ionic adsorption clay (IAC) rare earth minerals in Brazil.
- Initial phase focuses on mining and beneficiation, producing monazite concentrate and mixed rare earth carbonate (MREC).
- Scalable modular development plan allows phased expansion to match market demand.
- The PFS anticipates strong financial performance, including rapid payback period and high internal rate of return (IRR).
- Significant exploration upside exists at Colossus, with opportunities to expand resources and extend mine life.
- Environmental, social, and governance (ESG) initiatives include renewable energy use, low water consumption, and community engagement.
- The project is strategically positioned to become a leading non-Chinese supplier of key rare earths required for electric vehicles, wind turbines, and other green technologies.
- Strong support from Brazilian authorities and favorable permitting environment.
- Viridis Mining and Minerals is well-funded to advance Colossus into the next stages of development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$7,150 |
Suspension from Quotation
|
9 Jul 2025 9:30AM |
$4.950 |
$25.200 |
risen by
409.09%
|
|
AII - Price-sensitive ASX Announcement
Full Release
Key Points
- Almonty Industries Inc. (AII) securities are suspended from quotation as of 5 June 2024.
- The suspension is due to the company's failure to lodge its periodic report by the prescribed deadline.
- The ASX Listing Rules require timely lodgment of periodic reports for continued quotation.
- If Almonty does not lodge the required report within five business days, its securities may be removed from quotation.
- The company may apply for removal from the official list if required.
- The announcement details ASX procedures and consequences for non-compliance with listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$883 |
Appendix 3Y - Rachel Wiseman
|
9 Jul 2025 9:29AM |
$4.520 |
$2.440 |
fallen by
46.02%
|
|
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,011 |
Application for quotation of securities - SRL
|
9 Jul 2025 9:25AM |
$1.030 |
$13.090 |
risen by
1,170.87%
|
|
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$21 |
Section 708A Cleansing Notice
|
9 Jul 2025 9:24AM |
$0.029 |
$0.011 |
fallen by
62.07%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$104 |
Investor presentation
|
9 Jul 2025 9:22AM |
$0.145 |
$0.350 |
risen by
141.38%
|
|
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$21 |
Application for quotation of securities - VHL
|
9 Jul 2025 9:22AM |
$0.029 |
$0.011 |
fallen by
62.07%
|
|
| NetLinkz Limited (NET) ORDINARY FULLY PAID |
Information Technology |
- |
Kognitive Networks Partners with NET and Securelink Networks
|
9 Jul 2025 9:21AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$560 |
Change of Director's Interest Notice
|
9 Jul 2025 9:20AM |
$3.320 |
$2.500 |
fallen by
24.70%
|
|
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Company Update
|
9 Jul 2025 9:19AM |
$0.006 |
$0.009 |
risen by
50%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anatara Lifesciences Ltd is developing gastrointestinal health products for human and animal markets.
- The company’s key products are GaRP (for human health) and 3FLEX (for animal health).
- Multiple pre-clinical and non-clinical studies have shown promising results.
- The company is actively pursuing regulatory submissions and commercial partnerships.
- Cash reserves and a lean cost structure place Anatara in a stable financial position to execute its strategy.
- ANR is focused on progressing licensing deals and market entry for both its human and animal health products.
- Strategic priorities include advancing regulatory approvals, expanding commercial relationships, and maximizing shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$883 |
Becoming a substantial holder
|
9 Jul 2025 9:19AM |
$4.520 |
$2.440 |
fallen by
46.02%
|
|
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$21 |
Application for quotation of securities - VHL
|
9 Jul 2025 9:19AM |
$0.029 |
$0.011 |
fallen by
62.07%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,158 |
Update - Notification of buy-back - GNC
|
9 Jul 2025 9:17AM |
$7.560 |
$5.210 |
fallen by
31.08%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$104 |
Portfolio expansion achieved with acquisition of Galidesivir
|
9 Jul 2025 9:16AM |
$0.145 |
$0.350 |
risen by
141.38%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited acquired Galidesivir from BioCryst Pharmaceuticals.
- Galidesivir is a broad-spectrum antiviral with potential applications against multiple viral infections.
- The acquisition aligns with Island's strategy to expand its antiviral portfolio, especially targeting mosquito-borne diseases.
- Strategic rationale includes portfolio diversification, increased pipeline value, and enhanced market position in infectious disease therapeutics.
- The addition of Galidesivir is anticipated to provide new opportunities for clinical development and commercialization.
- The transaction underscores Island’s commitment to addressing global health challenges with innovative antiviral solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$56 |
Investor Presentation
|
9 Jul 2025 9:15AM |
$0.183 |
$0.051 |
fallen by
72.05%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$7 |
Test work underway for rutile & gallium by-product potential
|
9 Jul 2025 9:15AM |
$0.079 |
$0.072 |
fallen by
8.86%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingsland Minerals Ltd is conducting test work for rutile and gallium by-product potential at the Leliyn Graphite Project.
- ALS Metallurgy has been engaged for mineralogical and metallurgical studies on recent drill samples.
- Test work aims to assess the presence and recovery of rutile and gallium, which are classified as critical minerals.
- Positive results could add significant value to the graphite project.
- There is strong global demand for both rutile and gallium due to their strategic applications.
- Graphite resource and metallurgical studies are continuing in parallel to the by-product investigations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$27 |
Quarterly activities and cashflow report
|
9 Jul 2025 9:14AM |
$0.160 |
$0.225 |
risen by
40.63%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commissioning and operation of the SPN pilot plant with initial SPN production.
- Progress towards customer qualification and engagement with offtake partners for SPN.
- Advancements in graphene additives business, including environmentally friendly coatings development.
- Receipt of grant funding to support further research and product development.
- Summary of cash outflows and a positive cash position at the end of the quarter.
- Strategic focus on stakeholder engagement and advancing commercial discussions.
- Outlining the company's pathway and objectives for the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$56 |
Proposed issue of securities - NMR
|
9 Jul 2025 9:12AM |
$0.183 |
$0.051 |
fallen by
72.05%
|
|
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$56 |
$10M Share Placement for Blackjack Gold Production Ramp-Up
|
9 Jul 2025 9:12AM |
$0.183 |
$0.051 |
fallen by
72.05%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- NMR has announced a $10 million share placement to fund the ramp-up of gold production at the Blackjack Gold Project.
- The placement was strongly supported by institutional and sophisticated investors, resulting in approximately 222.2 million new fully paid ordinary shares to be issued at $0.045 per share.
- The funds raised will primarily be used for mine development, plant upgrades, working capital, and associated costs to ramp up gold production.
- Blackjack Gold Project is located in North Queensland, Australia, and is a key asset for NMR's growth strategy.
- The placement strengthens NMR’s balance sheet and positions the company for accelerated development of the Blackjack Project.
- NMR’s management considers the placement a significant endorsement of its strategy and resource potential.
- The company has set clear milestones for the use of proceeds, including commencing gold production ramp-up activities and advancing exploration at adjacent targets.
- The placement is not subject to shareholder approval, with settlement expected within days of the announcement.
- Directors and management are participating in the placement alongside external investors, further demonstrating confidence in the project.
- NMR has also provided an update on the status of permitting, plant refurbishment, and expected production timelines for the Blackjack Gold Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strickland Metals Limited (STK) ORDINARY FULLY PAID |
Materials |
$356 |
Further High-Grade Gold Intercepts at Gradina
|
9 Jul 2025 9:12AM |
$0.145 |
$0.135 |
fallen by
6.90%
|
|
STK - Price-sensitive ASX Announcement
Full Release
Key Points
- Strickland Metals Limited reported additional high-grade gold intercepts at Gradina.
- Recent drilling has resulted in multiple significant gold mineralization intersections.
- The results reinforce the potential for a large and high-quality gold system at Gradina.
- Future exploration will focus on systematic drilling to further define mineralization.
- The announcement underscores Gradina’s role in the company’s growth strategy.
- Upcoming activities will aim to support resource estimation and further discoveries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$236 |
Strong Leach Recoveries and Low Impurities
|
9 Jul 2025 9:11AM |
$0.235 |
$0.410 |
risen by
74.47%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- High TREO recoveries up to 82% achieved with hydrochloric acid leaching at the Halleck Creek project.
- Metallurgical testwork demonstrates consistent leach performance across various ore types.
- Low levels of impurities and radioactive elements found in product solutions.
- Results support a simplified and potentially lower-cost processing flowsheet.
- Strong leach recoveries and low impurities de-risk the Halleck Creek project.
- Findings align with ARR's strategy to develop a sustainable U.S. rare earth supply chain.
- Testwork strengthens the economic and environmental profile of the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blackstone Minerals Limited (BSX) ORDINARY FULLY PAID |
Materials |
$88 |
High Grade Cu-Au at Surface Delivers New Targets at Mankayan
|
9 Jul 2025 9:09AM |
$0.073 |
$0.051 |
fallen by
30.14%
|
|
BSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant high-grade copper-gold mineralization identified at surface at the Mankayan Project.
- Channel and rock chip sampling returned grades up to 8.15% copper and 3.63g/t gold.
- Results confirm the potential for both open pit and underground resource development.
- Exploration work has expanded the mineralized footprint and generated new targets.
- Additional drilling and geophysical surveys are planned to refine exploration and development strategies.
- Strong geological evidence supports the potential for an economically viable resource.
- The company is focused on advancing the project towards resource delineation and potential development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BMG Resources Limited (BMG) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
9 Jul 2025 9:08AM |
$0.010 |
$0.035 |
risen by
250%
|
|
BMG - Price-sensitive ASX Announcement
Full Release
Key Points
- BMG Resources Limited requested a trading halt from the ASX effective 14 April 2022.
- The trading halt is in relation to a proposed capital raising.
- The company seeks to ensure trading occurs on a fully informed basis.
- The trading halt will remain until either an announcement is made or trading resumes on 19 April 2022.
- The company is acting in compliance with ASX Listing Rule requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Evergold Minerals Limited (EG1) ORDINARY FULLY PAID |
Materials |
$10 |
EG1 commences exploration at Leonora Goldfields Project, WA
|
9 Jul 2025 9:08AM |
$0.032 |
$0.024 |
fallen by
25%
|
|
| APA Group (APA) FULLY PAID UNITS STAPLED SECURITIES |
Utilities |
$13,979 |
APA finalises project agreements with CS Energy
|
9 Jul 2025 9:07AM |
$8.340 |
$10.560 |
risen by
26.62%
|
|
Call 1300 880 160
Start a chat
Schedule a call
